|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Interferon alfa2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C显示文摘 | McHutchison JG Gordon SC Schiff ER Shiffrnan ML Lee WM Rustgi VK Goodman ZD Ling MH Cort S Albrecht JK | | 0，，： | 1 |
| 2 | The epidemiology of hepatitis C infection in the United States 显示文摘 | Rustgi VK | 2007 | J Gastroenterol2007，42，7： | 1 |
| 3 | Thymalfasin for the treatment of chronic hepatitis Cinfection显示文摘 | Rustgi VK | 2005 | Expert Rev Anti Infect Ther2005，3，6： | 1 |
| 4 | Safety and antiviral activity of ANA598 in combination with pegylated interferon α2A plus ribavirin in treatment-naive genotype-1 chronic HCV patients显示文摘 | Lawitz E Rodriquez-Torres M Rustgi VK | | 0，，1： | 1 |
| 5 | Albinterferon alia -2b, a novel fusion protein of human albumin and human interferon alia--2b, for chronie hepatitis C显示文摘 | Rustgi VK | 2009 | Curr Med Res Opin2009，25，4： | 1 |
| 6 | Epidemiology of hepatocellular carcinoma 显示文摘 | Rustgi VK | 1987 | Gastroenterol Clin Noah Am1987，16，： | 1 |
| 7 | Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial显示文摘 | Pol S Ghali RH Rustgi VK | 2012 | Lancet Infect Dis2012，12，9： | 1 |
| 8 | Therapy of chronic Hepatitis B with recombinant human alpha and gamma interferon显示文摘 | Di-Bisceglie AM Rustgi VK Kassianides C | 1990 | Hepatology1990，11，2： | 1 |
| 9 | Future trends in hepatology: challenges and opportunities 显示文摘 | Rustgi VK Davis GL Herrine SK | 2008 | Hepatology2008，48，2： | 1 |
| 10 | NIH conference: Hepatocellular carcinoma显示文摘 | Di Bisceqlie AM Rustgi vk Hoofnaqle JH | 1988 | Ann Intern Med1988，1083，： | 1 |
| 11 | Albinterferon alfa-2b, a novel fusion protein of human albumin and human interferon alfa-2b, for chronic hepatitis C显示文摘 | Rustgi VK | 2009 | Curr Med Res Opin2009，25，99： | 1 |
| 12 | The epidemiology of hepatitis C infection in the Unit- ed States显示文摘 | Rustgi VK | 2007 | J Gastroenterol2007，42，5： | 1 |
| 13 | Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection:a randomised,parallel-group,double-blind,placebo-controlled,dose-finding,phase 2a trial显示文摘 | Pol S Ghalib RH Rustgi VK | 2012 | Lancet Infect Dis2012，12，9： | 1 |
| 14 | Hepatocellular carcin oma显示文摘 | Rustgi VK Hoofnagle JH | 1988 | Ann Intern Med1988，108，： | 1 |
| 15 | Albinterferon alfa-2b,a novel fusion protein of human albumin and human interferon alfa-2b,for chronic hepatitis C显示文摘 | Rustgi VK | | 0，，04： | 1 |
| 16 | First report of SVR12 fora NS5A replication complex inhibitor BMS-790052 in combination with PEG-IFNa-2A and RBV: phase 2A trial in treatment-naive HCV-genotype-1 subjects 显示文摘 | Pol S Ghalib RH Rustgi VK | 2011 | J Hepatol2011，54，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员